Molecular structure and stereoelectronic properties of sarmazenil--a weak inverse agonist at the omega modulatory sites (benzodiazepine receptors): comparison with bretazenil and flumazenil.

X-ray diffraction and ab initio MO theoretical calculations were used in order to investigate the structural and electronic properties of sarmazenil, a weak inverse agonist at the omega modulatory sites (benzodiazepine receptors). This compound was compared to bretazenil, a partial agonist, and to the antagonist flumazenil on the basis of structural and electronic data. The conformational and theoretical properties (interatomic pi overlap populations, molecular electrostatic potential (MEP), the topology of frontier orbitals, and proton affinity) of these three imidazobenzodiazepinones were determined in order to analyse the stereoelectronic properties in relation with their distinct intrinsic efficacies at the omega modulatory sites.

[1]  P. Ros.  Nonempirical Molecular‐Orbital Calculations for Protonated Formaldehyde, Acetaldehyde, and Formic Acid , 1968 .

[2]  P. W. Codding,et al.  Synthesis of novel 3-substituted beta-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore. , 1988, Journal of medicinal chemistry.

[3]  D. Nutt,et al.  Antagonizing the anticonvulsant effect of ethanol using drugs acting at the benzodiazepine/GABA receptor complex , 1988, Pharmacology Biochemistry and Behavior.

[4]  E. Costa,et al.  The Benzodiazepines: From molecular biology to clinical practice , 1983 .

[5]  I. Martin,et al.  Multiple benzodiazepine receptors: no reason for anxiety. , 1992, Trends in pharmacological sciences.

[6]  J. Dreyfus,et al.  Pharmacological and clinical studies of cyclopyrrolones: Zopiclone and suriclone , 1984, Pharmacology Biochemistry and Behavior.

[7]  I. Gath,et al.  Electrophysiological aspects of benzodiazepine antagonists, Ro 15-1788 and Ro 15-3505. , 1984, British journal of clinical pharmacology.

[8]  N. W. Gilman,et al.  III. Conformational shifts at the benzodiazepine receptor related to the binding of agonists antagonists and inverse agonists , 1986 .

[9]  T. Caronna,et al.  Correlation of 2-, 3-, 4- and disubstituted pyridine gas-phase proton affinities with ab initio calculated energies at the STO-3G basis set level , 1992 .

[10]  C. Braestrup,et al.  Benzodiazepine receptor ligands with positive and negative efficacy , 1983, Neuropharmacology.

[11]  R. Olsen.  Drug interactions at the GABA receptor-ionophore complex. , 1982, Annual review of pharmacology and toxicology.

[12]  R. Olsen,et al.  A novel α subunit in rat brain GABAA receptors , 1989, Neuron.

[13]  J. D. Bene,et al.  A molecular orbital study of protonation substituted carbonyl compounds , 1976 .

[14]  P. Seeburg,et al.  Sequence and expression of human GABAA receptor α1 and β1 subunits , 1989 .

[15]  J. Rossier,et al.  Methyl-β-carboline-induced convulsions are antagonized by Ro 15-1788 and by propyl-β-carboline , 1982 .

[16]  E. Sigel,et al.  The γ3‐subunit of the GABAA‐receptor confers sensitivity to benzodiazepine receptor ligands , 1991 .

[17]  G. Loew,et al.  Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site. , 1994, Bioorganic & medicinal chemistry.

[18]  James A. Ibers,et al.  International tables for X-ray crystallography , 1962 .

[19]  D. Nutt,et al.  Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding sites--current status. , 1993, Nuclear medicine and biology.

[20]  P. Seeburg,et al.  Two novel GABAA receptor subunits exist in distinct neuronal subpopulations , 1989, Neuron.

[21]  Hannah Monyer,et al.  Cerebellar GABAA receptor selective for a behavioural alcohol antagonist , 1990, Nature.

[22]  J. Lambert,et al.  The interaction of the β-carboline derivative DMCM with inhibitory amino acid responses on cultured mouse neurones , 1983, Neuroscience Letters.

[23]  R. S. Mulliken.  Electronic Population Analysis on LCAO–MO Molecular Wave Functions. I , 1955 .

[24]  W. Haefely.  Pharmacology of the benzodiazepine receptor , 2004, European archives of psychiatry and neurological sciences.

[25]  L. Pieri,et al.  Selective antagonists of benzodiazepines , 1981, Nature.

[26]  C. Gardner,et al.  The rapidly expanding range of neuronal benzodiazepine receptor ligands , 1993, Progress in Neurobiology.

[27]  P. Skolnick,et al.  Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester. , 1990, Journal of medicinal chemistry.

[28]  S. Z. Langer,et al.  Imidazopyridines as a tool for the characterization of benzodiazepine receptors: A proposal for a pharmacological classification as omega receptor subtypes , 1988, Pharmacology Biochemistry and Behavior.

[29]  C. Gardner.  Pharmacological profiles in vivo of benzodiazepine receptor ligands , 1988 .

[30]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[31]  B. Scatton,et al.  Autoradiographic Localization of [3H]Zolpidem Binding Sites in the Rat CNS: Comparison with the Distribution of [3H]Flunitrazepam Binding Sites , 1987, Journal of neurochemistry.

[32]  G. Zbinden,et al.  Pharmacology of benzodiazepines: laboratory and clinical correlations. , 1967, Advances in pharmacology.

[33]  J. B. Collins,et al.  Self‐consistent molecular orbital methods. XVII. Geometries and binding energies of second‐row molecules. A comparison of three basis sets , 1976 .

[34]  S. Antonarakis,et al.  Cloning of the gamma-aminobutyric acid (GABA) rho 1 cDNA: a GABA receptor subunit highly expressed in the retina. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Costa,et al.  Molecular mechanisms of the partial allosteric modulatory effects of bretazenil at gamma-aminobutyric acid type A receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Y. Le Page,et al.  MISSYM1.1 – a flexible new release , 1988 .

[37]  D. Stephens,et al.  Evaluation of the β-carboline ZK 93 426 as a benzodiazepine receptor antagonist , 2004, Psychopharmacology.

[38]  G. Biggio,et al.  Modulation of GABA-stimulated chloride influx by β-carbolines in rat brain membrane vesicles , 1988, Brain Research.

[39]  Y. L. Page,et al.  Application of a segment description of the unique set of reflections to data collection and data reduction , 1979 .

[40]  Peter S. White,et al.  NRCVAX ― an interactive-program system for structure analysis , 1989 .

[41]  E. Sigel,et al.  Functional expression and sites of gene transcription of a novel α subunit of the GABAA receptor in rat brain , 1990 .

[42]  P. Seeburg,et al.  Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology , 1989, Nature.